EQUIFAX INC — Director's Dealing 2026

Feb 12, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EQUIFAX INC (EFX)
CIK: 0000033185
Period of Report: 2026-02-10

Reporting Person: Begor Mark W (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-10	Common Stock	M	37791.0000	$112.4600	Acquired	236778.0000	Direct
2026-02-10	Common Stock	A	33278.0000	$0.0000	Acquired	270056.0000	Direct
2026-02-10	Common Stock	S	201.0000	$197.7889	Disposed	269855.0000	Direct
2026-02-10	Common Stock	S	213.0000	$203.7607	Disposed	269642.0000	Direct
2026-02-10	Common Stock	S	227.0000	$192.8855	Disposed	269415.0000	Direct
2026-02-10	Common Stock	S	331.0000	$194.2210	Disposed	269084.0000	Direct
2026-02-10	Common Stock	S	364.0000	$195.3979	Disposed	268720.0000	Direct
2026-02-10	Common Stock	S	445.0000	$196.4280	Disposed	268275.0000	Direct
2026-02-10	Common Stock	S	829.0000	$199.0010	Disposed	267446.0000	Direct
2026-02-10	Common Stock	F	1759.0000	$202.7100	Disposed	265687.0000	Direct
2026-02-10	Common Stock	S	1772.0000	$200.0293	Disposed	263915.0000	Direct
2026-02-10	Common Stock	S	4057.0000	$201.2626	Disposed	259858.0000	Direct
2026-02-10	Common Stock	S	11000.0000	$203.0792	Disposed	248858.0000	Direct
2026-02-10	Common Stock	S	18352.0000	$202.1545	Disposed	230506.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-10	Stock Option/Right to Buy	$112.4600	M	37791.0000	Disposed	2028-05-04	Common Stock (37791.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10500.0000	Indirect
Common Stock	21284.0000	Indirect
Common Stock	22045.0000	Indirect
Common Stock	12333.0000	Indirect
Common Stock	16287.0000	Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025.

F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.

F3: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $197.524 to $198.008, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F4: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $203.675 to $203.85, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F5: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $192.556 to $193.366, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F6: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $193.735 to $194.661, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F7: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $194.892 to $195.779, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F8: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $196.123 to $196.912, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F9: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $198.645 to $199.62, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F10: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $199.67 to $200.481, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F11: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $200.672 to $201.66, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F12: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $202.665 to $203.64, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F13: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $201.67 to $202.66, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F14: The option vested in three equal annual increments beginning 5/4/2019.